EUVIMEDEUVIMED entdecken
Open Access

Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease

Na Xu iD, Christina M Alfieri, Yang Yu, Minzhe Guo iD, Katherine E Yutzey iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024

DOI: 10.1161/atvbaha.123.320388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Na Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Cardiovascular Biology, the Heart Institute (N.X., C.M.A., K.E.Y.), Cincinnati Children's Hospital Medical Center, OH. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Disease Progression, Fibrillin-1, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myxomatous valve disease (MVD) is the most common cause of mitral regurgitation, leading to impaired cardiac function and heart failure. MVD in a mouse model of Marfan syndrome includes valve leaflet thickening and progressive valve degeneration. However, the underlying mechanisms by which the disease progresses remain undefined. METHODS: Mice with Fibrillin 1 gene variant Fbn1 C1039G/+ recapitulate histopathologic features of Marfan syndrome, and Wnt (Wingless-related integration site) signaling activity was detected in TCF/Lef-lacZ (T-cell factor/lymphoid enhancer factor-β-galactosidase) reporter mice. Single-cell RNA sequencing was performed from mitral valves of wild-type and Fbn1 C1039G/+ mice at 1 month of age. Inhibition of Wnt signaling was achieved by conditional induction of the secreted Wnt inhibitor Dkk1 (Dickkopf-1) expression in periostin-expressing valve interstitial cells of Periostin -Cre; tetO-Dkk1; R26rtTA; TCF/Lef-lacZ; Fbn1 C1039G/+ mice. Dietary doxycycline was administered for 1 month beginning with MVD initiation (1-month-old) or MVD progression (2-month-old). Histological evaluation and immunofluorescence for ECM (extracellular matrix) and immune cells were performed. RESULTS: Wnt signaling is activated early in mitral valve disease progression, before immune cell infiltration in Fbn1 C1039G/+ mice. Single-cell transcriptomics revealed similar mitral valve cell heterogeneity between wild-type and Fbn1 C1039G/+ mice at 1 month of age. Wnt pathway genes were predominantly expressed in valve interstitial cells and valve endothelial cells of Fbn1 C1039G/+ mice. Inhibition of Wnt signaling in Fbn1 C1039G/+ mice at 1 month of age prevented the initiation of MVD as indicated by improved ECM remodeling and reduced valve leaflet thickness with decreased infiltrating macrophages. However, later, Wnt inhibition starting at 2 months did not prevent the progression of MVD. CONCLUSIONS: Wnt signaling is involved in the initiation of mitral valve abnormalities and inflammation but is not responsible for later-stage valve disease progression once it has been initiated. Thus, Wnt signaling contributes to MVD progression in a time-dependent manner and provides a promising therapeutic target for the early treatment of congenital MVD in Marfan syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt Signaling PathwayDisease ProgressionFibrillin-1Disease Models, AnimalMitral ValveAnimalsMiceIntercellular Signaling Peptides and ProteinsMice, TransgenicMarfan SyndromeMitral Valve InsufficiencyMice, Inbred C57BLInflammationMaleFemaleCell Adhesion MoleculesAdipokines

Stichwörter der Autor:innen

Wnt signaling pathwayendothelial cellsinflammationmitral valveperiostin

Substanzen

Fibrillin-1Fbn1 protein, mouseDkk1 protein, mouseIntercellular Signaling Peptides and ProteinsPostn protein, mouseCell Adhesion MoleculesAdipokines

Autor:innen und Institutionen

  • Division of Molecular Cardiovascular Biology, the Heart Institute (N.X., C.M.A., K.E.Y.), Cincinnati Children's Hospital Medical Center, OH.
  • Department of Pediatrics, University of Cincinnati College of Medicine, OH (N.X., M.G., K.E.Y.).
  • Division of Developmental Biology (Y.Y.), Cincinnati Children's Hospital Medical Center, OH.
  • Division of Neonatology and Pulmonary Biology (M.G.), Cincinnati Children's Hospital Medical Center, OH.

ORCID-Profile: Na Xu, Minzhe Guo, Katherine E Yutzey

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS

Zitieren

APA

Xu, N., Alfieri, C. M., Yu, Y., Guo, M., & Yutzey, K. E. (2024). Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320388

Vancouver

Xu N, Alfieri CM, Yu Y, Guo M, Yutzey KE. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.320388

BibTeX
@article{Xu2024,
  author = {Xu, Na and Alfieri, Christina M and Yu, Yang and Guo, Minzhe and Yutzey, Katherine E},
  title = {Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  doi = {10.1161/atvbaha.123.320388}
}
Kostenlos starten →